Final answer:
The first sentence in the specified article is "Parkinson's disease is the second most common age-related neurodegenerative disorder, typified by the progressive loss of substantia nigra pars compacta dopamine neurons and the consequent decrease in the neurotransmitter dopamine."
Step-by-step explanation:
The abstract of Feng, L. R., and K. A. Maguire-Zeiss. "Gene Therapy in Parkinson's Disease: Rationale and Current Status." is d. Parkinson's disease is the second most common age-related neurodegenerative disorder, typified by the progressive loss of substantia nigra pars compacta dopamine neurons and the consequent decrease in the neurotransmitter dopamine.
Parkinson's disease (PD) is characterized by the loss of dopaminergic neurons within the substantia nigra pars compacta (SNc) leading to motor symptoms such as tremors and rigidity. These neurons are essential in the modulation of movement via the neurotransmitter dopamine. As the disease progresses, treatments like L-DOPA are used to increase dopamine levels and alleviate symptoms, although there is no cure for PD. Additionally, cognitive and psychological symptoms such as dementia or depression are prevalent as PD advances.